NCT04140500 2026-03-18Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid TumorsHoffmann-La RochePhase 1/2 Active not recruiting170 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT05914116 2025-11-21A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting862 enrolled
NCT05144698 2025-05-14RAPA-201 Therapy of Solid TumorsRapa Therapeutics LLCPhase 1/2 Recruiting37 enrolled